Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ VivoPower Announces XRP-Focused Digital Asset Treasury Strategy and US$121 Million Private Placement... (GlobeNewswire EN) +++ VIVOPOWER Aktie +3,01%

HOLOGIC Aktie

 >HOLOGIC Aktienkurs 
57.5 EUR    +4.6%    (Tradegate)
Ask: 57 EUR / 1410 Stück
Bid: 56.5 EUR / 1420 Stück
Tagesumsatz: 6047 Stück
Realtime Kurs von 8 bis 22 Uhr!
HOLOGIC Aktie über LYNX handeln
>HOLOGIC Performance
1 Woche: +8,5%
1 Monat: +6,9%
3 Monate: -11,4%
6 Monate: -27,8%
1 Jahr: -20,4%
laufendes Jahr: -21,0%
>HOLOGIC Aktie
Name:  HOLOGIC INC. DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US4364401012 / 879100
Symbol/ Ticker:  HO1 (Frankfurt) / HOLX (NASDAQ)
Kürzel:  FRA:HO1, ETR:HO1, HO1:GR, NASDAQ:HOLX
Index:  S&P500
Webseite:  https://www.hologic.com/
Marktkapitalisierung:  10720 Mio. EUR
Umsatz:  3541.5 Mio. EUR
EBITDA:  1098.48 Mio. EUR
Gewinn je Aktie:  1.854 EUR
Schulden:  2223.33 Mio. EUR
Liquide Mittel:  1432.42 Mio. EUR
Umsatz-/ Gewinnwachstum:  -1.2% / -
KGV/ KGV lG:  22.56 / 12.94
KUV/ KBV/ PEG:  3.11 / 2.59 / 1.2
Gewinnm./ Eigenkapitalr.:  13.83% / 11.77%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 300.760 USD.
Suchwörter:  HOLOGIC
Letzte Datenerhebung:  28.05.25
>HOLOGIC Eigentümer
Aktien: 222.84 Mio. St.
f.h. Aktien: 220.73 Mio. St.
Insider Eigner: 0.86%
Instit. Eigner: 102.75%
>HOLOGIC Peer Group

 
28.05.25 - 14:03
Forecasting The Future: 6 Analyst Projections For Hologic (Benzinga)
 
Latest Ratings for HOLX DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsOverweight Feb 2022Raymond JamesMaintainsOutperform View More Analyst Ratings for HOLX View the Latest Analyst Ratings read more...
28.05.25 - 07:21
Medizingeräte-Hersteller Hologic lehnt 16-Mrd-Offerte ab (Reuters)
 
Um den gesamten Artikel unter onvista.de zu lesen, klicken Sie bitte auf die Überschrift...
28.05.25 - 06:42
Medizingeräte-Hersteller Hologic lehnt Milliarden-Übernahmeangebot ab (Cash)
 
Gesundheit - Der Medizingerätehersteller Hologic hat ein Übernahme-Angebot in Höhe von bis zu 16,7 Milliarden Dollar abgelehnt....
27.05.25 - 22:18
Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday? (Benzinga)
 
Hologic declined a $16 billion buyout bid from TPG and Blackstone as it faces falling shares and tariff-related headwinds, leaving room for deal talks to potentially resume. read more...
27.05.25 - 20:03
Hologic rises after report on take-private offer from TPG/ Blackstone (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
27.05.25 - 16:00
HOLX vs. DGX: Which Women′s Health-Focused Stock Is the Better Pick? (Zacks)
 
The women's health market is booming, with Hologic and Quest Diagnostics leading the charge. But which one stands out more for investors today?...
19.05.25 - 16:45
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? (Zacks)
 
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store....
15.05.25 - 14:30
Hologic Stock: Is Wall Street Bullish or Bearish? (Barchart)
 
Despite Hologic's underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock's prospects....
12.05.25 - 16:00
Tariffs Dim Hologic′s 2025 Expectations: Time to Reassess the Stock? (Zacks)
 
HOLX displays cautious fiscal 2025 guidance in a challenging geopolitical and macroeconomic environment. What does it mean for the stock?...
10.05.25 - 02:01
Insiderhandel: Aufsichtsrat kauft Aktien von Hologic im Wert von 300760 USD (Insiderkauf)
 
Madaus, Martin D. - Aufsichtsrat - Tag der Transaktion: 2025-05-07...
02.05.25 - 15:15
Hologic Q2 Earnings & Revenues Top, ′25 EPS View Lowered, Stock Down (Zacks)
 
HOLX delivers earnings and revenue beat in the second quarter of fiscal 2025 amid macroeconomic turbulence....
02.05.25 - 02:30
Hologic outlines Q3 2025 revenue target of $1B-$1.01B amid breast health recovery (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.05.25 - 01:01
Hologic Posts Q2 Loss On Impairment Charges Despite Stable Revenue (AFX)
 
BEDFORD (dpa-AFX) - Hologic, Inc. (HOLX) Thursday reported a net loss for the fiscal second quarter ended March 29, driven by significant impairment charges, despite largely stable revenue year ov......
01.05.25 - 22:03
Hologic Announces Financial Results for Second Quarter of Fiscal 2025 (Business Wire)
 
– Revenue of $1,005.3 Million Slightly Exceeds Guidance – – Company Reports GAAP Diluted EPS of ($0.08); Non-GAAP Diluted EPS of $1.03 at High End of Guidance – – Company Maintains Annual Revenue Guidance, Lowers Guidance for GAAP and Non-GAAP EPS – MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal second quarter ended March 29, 2025. “We delivered on our financial commitments in the second quarter,” said Stephen P. MacMillan, the Company's Chairman, President and Chief Executive Officer. “Both revenue and non-GAAP EPS finished at the high ends of our guidance ranges, driven by our diagnostics and skeletal businesses, strong profitability, share buybacks and a slightly lower tax rate.” Recent Highlights Revenue of $1,005.3 million decreased (1.2%) for the quarter, or (0.5%) in constant currency. This compares to the guidance range of $995 to $1,005 million that the Company provided in earl...
28.04.25 - 16:00
GYN Surgical Division Likely to Drive Hologic′s Q2 Earnings (Zacks)
 
HOLX's second-quarter fiscal 2025 performance is likely to have benefited from expanding breast health offerings....
25.04.25 - 16:00
Hologic Set to Report Q2 Earnings: Buy, Sell or Hold the Stock? (Zacks)
 
Molecular Diagnostics is likely to have aided HOLX's performance in the second quarter of fiscal 2025....
22.04.25 - 17:30
Hologic vs. MYGN: Which Molecular Diagnostics Player Has More Upside? (Zacks)
 
Both HOLX and Myriad Genetics are longstanding key players in the Molecular Diagnostics space. But which one is a better investment now?...
22.04.25 - 01:01
Hologic (HOLX) Stock Moves -1.08%: What You Should Know (Zacks)
 
In the most recent trading session, Hologic (HOLX) closed at $56.94, indicating a -1.08% shift from the previous trading day....
21.04.25 - 10:42
Here€s What to Expect From Hologic′s Next Earnings Report (Barchart)
 
Hologic is scheduled to release its first-quarter results next month, and analysts are projecting single-digit dip in its bottom-line figure....
15.04.25 - 01:00
Why Hologic (HOLX) Outpaced the Stock Market Today (Zacks)
 
Hologic (HOLX) closed at $58.84 in the latest trading session, marking a +1.71% move from the prior day....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ehrlichkeit ist so gefährlich, daß sie einem das Herz brechen kann. - Margaret Millar
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!